Bradycardia
FDA approves expanded indication for pacing leads to include conduction pacing of LBB area
Boston Scientific announced it received FDA approval to expand the indication for its pacing leads to include conduction system pacing of the left bundle branch area when connected to a single- or dual-chamber pacemaker.
Olympus issues class I recall for insufflation unit after '10 serious injuries, one death'
The FDA has classified Olympus Medical’s recall of its high-flow abdominal insufflation device as class I, following reports of 21 malfunctions, 10 serious injuries and one death associated with over-inflation.
FDA approves first cardiac lead for new type of conduction system pacing
Medtronic announced its cardiac lead received an expanded indication from the FDA for left bundle branch area conduction system pacing for the treatment of bradycardia.
Single-chamber leadless pacemaker receives FDA approval to treat slow heart rhythms
Abbott announced that the FDA has approved its Aveir VR single-chamber leadless pacemaker for the treatment of bradycardia, according to a company press release.
Healthy sleep patterns may lower arrhythmia risk
Healthy sleep patterns may be associated with reduced risk for atrial fibrillation/atrial flutter and bradyarrhythmia, according to research published in the Journal of the American College of Cardiology.
FDA designates recall of two bradycardia pacemakers as Class I
The FDA has identified Abbott’s recall of two scalable bradycardia platform pacemakers as Class I, the most serious type of recall.
AHA: Risk reduction, appropriate action critical with drug-induced arrhythmias
Several drugs may exacerbate or cause arrhythmias, but risk reduction, drug discontinuation and treatment when appropriate may help prevent these conditions, according to a scientific statement from the American Heart Association.
Treatment of COVID-19 with lopinavir/ritonavir may raise bradycardia risk
Older patients with no preexisting nodal pathology who received lopinavir/ritonavir combination therapy for treatment of COVID-19 infection may experience bradycardia during hospitalization, researchers reported.
Insertable Bluetooth arrhythmia monitoring system nets FDA clearance
Boston Scientific announced it received clearance from the FDA for the company’s new insertable cardiac monitor system.
Disease severity, not myocardial infection, associated with arrhythmia, death in COVID-19
Among patients admitted with COVID-19, those transferred to the ICU were more likely to experience arrhythmias, cardiac arrest and death compared with patients who did not go to the ICU, researchers reported.